SCHEMBL4380562

SCHEMBL4380562

CC(N)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.46
ADRB2 P07550 1/20 0.45
IDO1 P14902 2/20 0.43
TDO2 P48775 2/20 0.43
PDE2A O00408 1/20 0.41
HSPB1 P04792 1/20 0.41
SCN4A P35499 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SCN9A Q15858 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
AOC3 Q16853 1/20 0.37
CARM1 Q86X55 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16649847 1.00 SOS1 (0.46) SOS1ADRB2IDO1TDO2PDE2A
Hydrochloric Acid SCHEMBL22159069 0.98 IDO1 (0.45) SOS1ADRB2IDO1TDO2PDE2A
Hydrochloric Acid SCHEMBL22159071 0.98 IDO1 (0.45) SOS1ADRB2IDO1TDO2PDE2A
SCHEMBL24152555 0.89 ADRB2 (0.54) ADRB2PDE2AALDH1A1MEN1KMT2A
SCHEMBL157927 0.87 ADRB2 (0.56) ADRB2IDO1TDO2PDE2AMAOA
SCHEMBL516801 0.87 ADRB2 (0.56) ADRB2IDO1TDO2PDE2AMAOA
SCHEMBL56723 0.87 ADRB2 (0.56) ADRB2IDO1TDO2PDE2AMAOA
Hydrochloric Acid SCHEMBL14576625 0.84 ADRB2 (0.54) ADRB2IDO1TDO2PDE2AMAOA
Bromide SCHEMBL25231048 0.84 ADRB2 (0.54) ADRB2IDO1TDO2PDE2AMAOA
Hydrochloric Acid SCHEMBL1887841 0.84 ADRB2 (0.54) ADRB2IDO1TDO2PDE2AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed